{"transactions":[{"id":811293,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-09T21:00:04.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":9185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":9185,"source":{"system":"sec-edgar","filing":"0001213900-26-042051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026042051/ownership.xml","form_type":"4"}},{"id":1127277,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T20:01:36.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."}],"balance_after":28000,"derivative":{"exercise_price":0.688,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001213900-25-050021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025050021/ownership.xml","form_type":"4"}},{"id":1559272,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T22:21:57.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024."}],"balance_after":12000,"derivative":{"exercise_price":1.35,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001213900-24-026725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390024026725/ownership.xml","form_type":"4"}},{"id":1877722,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T20:38:50.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."}],"balance_after":50000,"derivative":{"exercise_price":0.3025,"exercise_date":"2023-05-23","expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-23-043114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023043114/ownership.xml","form_type":"4"}},{"id":2371504,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-02-25T19:55:52.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."}],"balance_after":40000,"derivative":{"exercise_price":2,"exercise_date":"2022-03-23","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-22-009422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390022009422/ownership.xml","form_type":"4"}},{"id":2868632,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-10T22:48:48.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":40000,"derivative":{"exercise_price":3.11,"exercise_date":"2021-03-08","expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-21-008158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390021008158/ownership.xml","form_type":"4"}},{"id":3224206,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-03-06T00:22:41.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."}],"balance_after":60000,"derivative":{"exercise_price":1.44,"exercise_date":"2020-04-03","expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001213900-20-005549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390020005549/ownership.xml","form_type":"4"}},{"id":3854688,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:03:09.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":14000,"ownership":{"direct":false,"nature":"Owned by Keller Enterprises, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2018, Keller purchased 14,000 units (the \"Units\") in the initial public offering of the issuer at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 31, 2018, Keller purchased 14,000 units (the \"Units\") in the initial public offering of the issuer at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Gilliland is the principal of Keller Enterprises, LLC (\"Keller\")."}],"balance_after":43931,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":43931},"source":{"system":"sec-edgar","filing":"0001213900-18-010083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010083/ownership.xml","form_type":"4"}},{"id":3854687,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:03:09.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":29931,"ownership":{"direct":false,"nature":"Owned by Keller Enterprises, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 at a conversion price of $0.44 per share upon consummation of the initial public offering of the issuer on July 31, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Gilliland is the principal of Keller Enterprises, LLC (\"Keller\")."}],"balance_after":29931,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":29931},"source":{"system":"sec-edgar","filing":"0001213900-18-010083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010083/ownership.xml","form_type":"4"}},{"id":3854686,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2018-08-02T20:03:09.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":29931,"ownership":{"direct":false,"nature":"Owned by Keller Enterprises, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 at a conversion price of $0.44 per share upon consummation of the initial public offering of the issuer on July 31, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 at a conversion price of $0.44 per share upon consummation of the initial public offering of the issuer on July 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 at a conversion price of $0.44 per share upon consummation of the initial public offering of the issuer on July 31, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Gilliland is the principal of Keller Enterprises, LLC (\"Keller\")."}],"balance_after":0,"derivative":{"exercise_price":0.44,"underlying":"Common Stock","underlying_shares":29931},"source":{"system":"sec-edgar","filing":"0001213900-18-010083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010083/ownership.xml","form_type":"4"}},{"id":3854685,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:03:09.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":14000,"ownership":{"direct":false,"nature":"Owned by Keller Enterprises, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2018, Keller purchased 14,000 units (the \"Units\") in the initial public offering of the issuer at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 31, 2018, Keller purchased 14,000 units (the \"Units\") in the initial public offering of the issuer at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Gilliland is the principal of Keller Enterprises, LLC (\"Keller\")."}],"balance_after":109424,"source":{"system":"sec-edgar","filing":"0001213900-18-010083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010083/ownership.xml","form_type":"4"}},{"id":3854684,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53053,"kind":"person","name":"Gilliland Robertson H.","position":1,"cik":"0001718351","reported_name":"Gilliland Robertson H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:03:09.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":29931,"ownership":{"direct":false,"nature":"Owned by Keller Enterprises, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 at a conversion price of $0.44 per share upon consummation of the initial public offering of the issuer on July 31, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Gilliland is the principal of Keller Enterprises, LLC (\"Keller\")."}],"balance_after":95424,"source":{"system":"sec-edgar","filing":"0001213900-18-010083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010083/ownership.xml","form_type":"4"}}]}